Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group 2 Pulmonary Hypertension”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04175600
What this trial is testing

Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Actelion 138
Large-scale testing (Phase 3)Active Not RecruitingNCT05983250
What this trial is testing

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Who this might be right for
Pulmonary Hypertension
Tenax Therapeutics, Inc. 230
Large-scale testing (Phase 3)Enrolling By InvitationNCT07436689
What this trial is testing

Long-Term Open-Label Extension Study of Oral Levosimendan

Who this might be right for
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc. 800
Large-scale testing (Phase 3)Study completedNCT01392469
What this trial is testing

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 21
Large-scale testing (Phase 3)Study completedNCT01720524
What this trial is testing

Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn

Who this might be right for
Pulmonary Hypertension, Familial Persistent, of the Newborn
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 59
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Early research (Phase 1)WithdrawnNCT02684786
What this trial is testing

Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension

Who this might be right for
Pulmonary Artery Hypertension
Mayo Clinic
Not applicableLooking for participantsNCT06495970
What this trial is testing

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study)

Who this might be right for
Pulmonary Hypertension
Gradient Denervation Technologies 20
Not applicableStudy completedNCT05001711
What this trial is testing

Acute Assessment of the Aria CV System in Patients With WHO Groups 2 and 3 Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
Aria CV, Inc 18
Not applicableWithdrawnNCT05332873
What this trial is testing

Rivet PVS Therapy in Group 2 PH-HFpEF Canada

Who this might be right for
Heart FailurePulmonary Hypertension
NXT Biomedical
Testing effectiveness (Phase 2)Ended earlyNCT01725269
What this trial is testing

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT05737940
What this trial is testing

AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Who this might be right for
Pulmonary Hypertension (World Health Organization Group 2)Heart Failure
AstraZeneca 260
Post-approval studies (Phase 4)Looking for participantsNCT07147114
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Who this might be right for
Combined Pre- and Post-capillary Pulmonary HypertensionCpcPHHFmrEF+2 more
Gachon University Gil Medical Center 64
Not applicableUnknownNCT05856461
What this trial is testing

Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension

Who this might be right for
Atrial FibrillationPulmonary Hypertension
Meshalkin Research Institute of Pathology of Circulation 116
Large-scale testing (Phase 3)Looking for participantsNCT07288398
What this trial is testing

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Who this might be right for
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc. 540
Testing effectiveness (Phase 2)Ended earlyNCT03556020
What this trial is testing

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Who this might be right for
Pulmonary Arterial Hypertension
PhaseBio Pharmaceuticals Inc. 35
Not applicableEnrolling By InvitationNCT06052072
What this trial is testing

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Who this might be right for
Group 2 Pulmonary HypertensionHeart Failure
Gradient Denervation Technologies 50
Testing effectiveness (Phase 2)Looking for participantsNCT06846554
What this trial is testing

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd 48
Testing effectiveness (Phase 2)Ended earlyNCT03884465
What this trial is testing

Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil

Who this might be right for
Pulmonary Arterial Hypertension
Liquidia Technologies, Inc. 15
Next Page